Plain-English translation of NCT01660984 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term research study designed to follow people with medullary thyroid cancer (a rare type of thyroid cancer) or a genetic condition called MEN2 that causes it. By tracking your health over time through regular visits and tests, researchers hope to understand more about how this cancer develops, why some treatments work better than others, and how to create better treatments in the future.
Medullary thyroid cancer is hard to treat, and many people are diagnosed when the cancer is already advanced. Researchers don't yet fully understand why some patients develop resistance to existing medications or why treatments don't work the same way for everyone. This study aims to solve those mysteries so they can develop more effective treatments.
You would visit the NIH at regular intervals for appointments where doctors will perform medical evaluations, take blood samples or tissue samples, and review your medical history and current treatments. Parents or caregivers of young patients may also be asked to share information about their experiences and needs. The study continues over time, so you would stay involved for an extended period while researchers track how your condition changes and how your body responds to any treatments you receive.
AI-generated summary from trial data · Sep 3, 2026 · Not medical advice
United States